docetaxel anhydrous has been researched along with Carcinoid Tumor in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clark, JW; Fuchs, CS; Kim, H; Kulke, MH; Mayer, RJ; Ryan, DP; Stuart, K; Vincitore, M | 1 |
1 trial(s) available for docetaxel anhydrous and Carcinoid Tumor
Article | Year |
---|---|
A phase II study of docetaxel in patients with metastatic carcinoid tumors.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Disease-Free Survival; Docetaxel; Female; Gastrointestinal Neoplasms; Humans; Hydroxyindoleacetic Acid; Life Tables; Lung Neoplasms; Male; Middle Aged; Octreotide; Radiography; Salvage Therapy; Survival Analysis; Taxoids; Treatment Failure | 2004 |